Fosamax and Osteonecrosis of the Jaw, or Jaw Death

Full Video Transcript

Fosamax, a drug manufactured by Merick to treat osteoporosis and Paget’s disease, has been shown to cause osteonecrosis of the jaw, or dead jaw syndrome, a progressively debilitating condition that results in actual bone death. People turned to Fosamax to prevent bone loss, but were not warned that Fosamax could potentially do more harm than good. Not only does dead jaw syndrome cause severe pain and permanent damage, simply stopping taking Fosamax may not reduce your risk of dead jaw syndrome because the drug can stay in your body for up to 10 years. People taking Fosamax should consult with a doctor before having any major dental work done, as dental work can increase the risk of dead jaw syndrome. If you took Fosamax and later developed a serious side effect you may be entitled to compensation for your injuries. Talk to an experienced attorney to find out your legal options.